Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 2 48-2, 2003, Pages

  James, Arlene N ^a   Ryan, James P ^a   Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrointestinal smooth muscle; Gastroparesis

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH MUSCLE; STOMACH PARESIS;

EID: 0038102953     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00296.2002     Document Type: Article

References (26)

1. Bigalke H and Habermann E. Blockade by tetanus and botulinum toxin A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 312: 255-263, 1980.
2. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, de Camilli P, Sudhof TC, Niemann H, and Jahn R. Botulinum toxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-163, 1993.
3. Camilleri M, Malagelada JR, Brown ML, Becker G, and Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol Gastrointest Liver Physiol 249: G580-G585, 1985.
4. Cellek S and Moncada S. Nitrergic modulation of cholinergic responses in the opossum lower esophageal sphincter. Br J Pharmacol 122: 1043-1046, 1997.
5. Crowell MD, Lacy BE, and Schettler-Duncan V. A botulinum toxin reduces pyloric dysfunction in patients with diabetic gastroparesis (Abstract). Gastroenterology 122: A451-A452, 2002.
6. De Camilli P. Exocytosis goes with a SNAP. Nature 364: 387-388, 1993.
7. Ezzedine D, Jit R, Katz N, Gopalswamy N, and Bhutani MS. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 55: 920-923, 2002.
8. Gupta P and Rao SSC. Attenuation of isolated pyloric pressure waves in gastroparesis in response to botuhnum toxin: a case report. Gastrointest Endosc 56: 770-772, 2002.
9. Hoogerwerf WA and Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am 11: 311-322, 2001.
10. Jankovic J and Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186-1194, 1991.
11. 2+ channel density differences along the cat smooth muscle esophagus and inhibition of the channel by SNAP-25 (Abstract). Gastroenterology 122: A164, 2002.
12. Ji J, Lau H, Sheu L, Diamant BE, and Gaisano HY. Distinct regional expression of SNARE proteins in the feline oesophagus. Neurogastroenterol Motil 14: 383-394, 2002.
13. + channels in esophageal smooth muscle. Gastroenterology 122: 994-1006, 2002.
14. Lacy BE, Zayat EN, Crowell MD, and Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 97: 1548-1552, 2002.
15. MacKenzie I, Burnstock G, and Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7: 997-1006, 1982.
16. Mearin F, Camilleri M, and Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90: 1919-1925, 1986.
17. Miller LS, Szych GA, Kantor SB, Bromer MQ, Knight LC, Maurer AH, Fisher RS, and Parkman HP. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 97: 1653-1660, 2002.
18. Morris JL, Jobling P, and Gibbins IL. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281: H2124-H2132, 2001.
19. Nakov R, Habermann E, Hertting G, Wurster S, and Allgaier L. Effects of botulinum A toxin on presynaptic modulation of evoked transmitter release. Eur J Pharmacol 164: 45-53, 1989.
20. Pasricha PJ, Ravich WJ, Hendrix TR, and Kaloo AV. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332: 774-778, 1995.
21. Pasricha PJ, Ravich WJ, and Kalloo KN. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105: 1045-1049, 1993.
22. Paul ML and Cook MA. Lack of effect of botulinum toxin on nonadrenergic, noncholinergic inhibitory responses of the guinea pig fundus in vitro. Can J Physiol Pharmacol 58: 88-92, 1980.
23. Sand J, Nordback I, Arvola P, Porsti I, Kalloo A, and Pasricha P. Effects of botulinum toxin A on the sphincter of Odd: an in vivo and in vitro study. Gut 42: 507-510, 1998.
24. Torbey CF, Singaram C, Bass P, and Gaumnitz EA. Action of botulinum toxin on gut smooth muscle involves cholinergic and non-cholinergic neural pathways (Abstract). Gastroenterology 112: A840, 1997.
25. 2+ channels. EMBO J 15: 4100-4110, 1996.
26. Zhai X and Pasricha PJ. Botulinum toxin for spastic GI disorders: a systematic review. Gastrointest Endosc 57: 219-235, 2003.